Literature DB >> 21615194

Osteocalcin is a stress-responsive neuropeptide.

P Patterson-Buckendahl1.   

Abstract

Osteocalcin (OC) is a small, acidic extracellular protein synthesized by osteoblasts during bone formation. 3 residues of gamma-carboxy glutamic acid, formed in a vitamin K dependent process, enable highly specific binding to ionic or bone mineral calcium. Some OC is released to circulation (pOC) and can serve as a biomarker of bone turnover. A series of experiments indicated that OC is stress-responsive in ways that vary with the type of stressor. Those in which the HPA axis predominates slowly decrease OC synthesis and secretion while sympathetic neural activation rapidly increases pOC. The advent of an OC null mutant mouse (KO) led to discovery of several functions for the protein outside the skeleton, most notably in regulation of energy metabolism. The KO mouse also exhibits numerous behavioral traits that are characteristic of sensory impairment. The discovery of OC protein in sensory ganglia stimulated further investigation of the interaction of sensory responses and both OC gene expression and OC protein in trigeminal and dorsal root ganglia. A recently discovered G-coupled protein receptor has been suggested as a potential OC receptor in combination with calcium ions. Because of the importance of ionic calcium to signal transduction in the nervous system, the presence of this unique calcium binding protein in neurons led to the hypothesis that OC functions as a neuropeptide. Implications of this potential new function are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21615194     DOI: 10.4149/endo_2011_02_99

Source DB:  PubMed          Journal:  Endocr Regul        ISSN: 1210-0668


  6 in total

Review 1.  Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

Authors:  G Targher; A Lonardo; M Rossini
Journal:  J Endocrinol Invest       Date:  2015-05-24       Impact factor: 4.256

2.  Evaluation of serum myostatin and sclerostin levels in chronic spinal cord injured patients.

Authors:  M Invernizzi; S Carda; M Rizzi; E Grana; D F Squarzanti; C Cisari; C Molinari; F Renò
Journal:  Spinal Cord       Date:  2015-04-21       Impact factor: 2.772

Review 3.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

4.  Sclerostin: a candidate biomarker of SCI-induced osteoporosis.

Authors:  L R Morse; S Sudhakar; A A Lazzari; C Tun; E Garshick; R Zafonte; R A Battaglino
Journal:  Osteoporos Int       Date:  2012-07-17       Impact factor: 4.507

Review 5.  Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.

Authors:  Alexander J Kovalic; George Cholankeril; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-03

6.  Early life stress is associated with earlier emergence of permanent molars.

Authors:  Cassidy L McDermott; Katherine Hilton; Anne T Park; Ursula A Tooley; Austin L Boroshok; Muralidhar Mupparapu; JoAnna M Scott; Erin E Bumann; Allyson P Mackey
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-15       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.